Accelerate Diagnostics Inc Ano de IPO
Qual é o Ano de IPO de Accelerate Diagnostics Inc?
O Ano de IPO de Accelerate Diagnostics Inc é 1996
Qual é a definição de Ano de IPO?
A oferta pública inicia (OPI)l é um tipo de oferta pública em que as ações de uma empresa geralmente são vendidas a investidores institucionais que, por sua vez, vendem para o público em geral, em uma bolsa de valores, pela primeira vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Ano de IPO de empresas na Setor Health Care em NASDAQ em comparação com Accelerate Diagnostics Inc
O que Accelerate Diagnostics Inc faz?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Empresas com ano de ipo semelhantes a Accelerate Diagnostics Inc
- Shaw Communications tem Ano de IPO de 1995
- Husky tem Ano de IPO de 1995
- Transcontinental , Cl B Mv tem Ano de IPO de 1995
- Mountain Inc tem Ano de IPO de 1995
- Brookfield Asset Management tem Ano de IPO de 1995
- ShawCor tem Ano de IPO de 1995
- Accelerate Diagnostics Inc tem Ano de IPO de 1996
- BXP tem Ano de IPO de 1997
- Faro Technologies tem Ano de IPO de 1997
- Silgan tem Ano de IPO de 1997
- Warrior Gold tem Ano de IPO de 1997
- Ryanair Plc tem Ano de IPO de 1997
- SIGA Technologies Inc tem Ano de IPO de 1997